IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Healthcare Value Capital, LLC

Q4 2018 Holdings

Filed 2019-02-13 | 10 holdings | $25.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tyme Technologies IncCOM90238J103$8.0K2,175,00031.2%
Fluidigm Corp del(LAB)COM34385P108$3.9K450,00015.1%
Glaxosmithkline PLCSPONSORED ADR37733W105$3.8K100,00014.9%
Proshares TRULTSH NASD BIOT74347B789$3.4K150,00013.4%
Allergan PLCSHSG0177J108$2.7K20,00010.4%
Novelion Therapeutics IncCOM NEW67001K202$1.5K1,800,0006.0%
Viking Therapeutics Inc(VKTX)CallCOM92686J106$765100,0003.0%
Viking Therapeutics Inc(VKTX)COM92686J106$765100,0003.0%
Antares Pharma Inc(ATRSEUR)COM036642106$680250,0002.6%
Lannet IncCallCOM516012101$12425,0000.5%